Version française

Stago at the Heart of Haemostasis

People dedicated to Health

From ideas...to medical applications

Complications of heparin treatment

In the absence of any straightforward laboratory tests, the most severe complication, known as type II heparin-induced thrombocytopenia (HIT) has...

From ideas...to medical applications

STA-Procoag-PPL or making microparticles talk

Midway between plasma haemostasis and cellular haemostasis are microparticles, rich in procoagulant phospholipids. An increase in this procoagulant...

From ideas...to medical applications

Remaining abreast of changes in biomedical science

Listening to and exchanging ideas with members of the biomedical science community has enabled Stago to develop its expertise in the search for...

From ideas...to medical applications

Complete industrial autonomy

Achieving a balanced policy with regard to investment in research & development (R&D), technological monitoring and rational acquisitions is a key...

Events

  • July 28 - August 1, 2013

  • AACC

All news

IPad app

This Ouvre un lien externe dans la fenêtre courantefree educational application in English is the first of its kind and has been developed by an expert in Haemostasis… Stago.

Products & Services

New range of STA®-Routine QC quality control plasmas: The best range for routine laboratory tests

To fulfil regulatory requirements, laboratories must perform regular internal quality control (IQC) on at least two concentration levels (normal and abnormal) to check and confirm the performance of their testing systems.

Stago Catalogue

Did you know?

In 1977, with Bjarne Østerud, Dr. S.I. Rapaport described the activation of factor IX by factor VIIa/tissue factor complex as an additional pathway in the initiation of blood coagulation.

RSS feed | Contact us | Credits and copyrights | Disclaimer | Site map |